GUNA-FLAM

Active substance: ACONITUM NAPELLUS, ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT, APIS MELLIFERA, ATROPA BELLADONNA, METENKEFALIN, BRYONIA ALBA ROOT, CITRIC ACID MONOHYDRATE, SUS SCROFA CONJUNCTIVA, BASIC CUPRIC CARBONATE, FERRIC PHOSPHATE, CALCIUM SULFIDE, SUS SCROFA PITUITARY GLAND, INTERLEUKIN-10, MELATONIN, SODIUM PYRUVATE, PHYTOLACCA AMERICANA ROOT, SUS SCROFA PINEAL GLAND, RANCID BEEF, TRANSFORMING GROWTH FACTOR BETA-1

SOLUTION/ DROPS · ACONITUM NAPELLUS 6 [hp_X]/30mL, ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT 4 [hp_C]/30mL, APIS MELLIFERA 6 [hp_X]/30mL, ATROPA BELLADONNA 6 [hp_X]/30mL, METENKEFALIN 6 [hp_X]/30mL, BRYONIA ALBA ROOT 6 [hp_X]/30mL, CITRIC ACID MONOHYDRATE 3 [hp_X]/30mL, SUS SCROFA CONJUNCTIVA 12 [hp_X]/30mL, BASIC CUPRIC CARBONATE 4 [hp_X]/30mL, FERRIC PHOSPHATE 6 [hp_X]/30mL, CALCIUM SULFIDE 6 [hp_X]/30mL, SUS SCROFA PITUITARY GLAND 200 [hp_X]/30mL, INTERLEUKIN-10 4 [hp_C]/30mL, MELATONIN 4 [hp_C]/30mL, SODIUM PYRUVATE 3 [hp_X]/30mL, PHYTOLACCA AMERICANA ROOT 6 [hp_X]/30mL, SUS SCROFA PINEAL GLAND 6 [hp_X]/30mL, RANCID BEEF 30 [hp_X]/30mL, TRANSFORMING GROWTH FACTOR BETA-1 4 [hp_C]/30mL

United StatesActive

Marketing holder: Guna spa

Verified 2026-10-09 · openFDA NDC

Source: openFDA NDC

Composition

ACONITUM NAPELLUS · 6 [hp_X]/30mL
ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT · 4 [hp_C]/30mL
APIS MELLIFERA · 6 [hp_X]/30mL
ATROPA BELLADONNA · 6 [hp_X]/30mL
METENKEFALIN · 6 [hp_X]/30mL
BRYONIA ALBA ROOT · 6 [hp_X]/30mL
CITRIC ACID MONOHYDRATE · 3 [hp_X]/30mL
SUS SCROFA CONJUNCTIVA · 12 [hp_X]/30mL
BASIC CUPRIC CARBONATE · 4 [hp_X]/30mL
FERRIC PHOSPHATE · 6 [hp_X]/30mL
CALCIUM SULFIDE · 6 [hp_X]/30mL
SUS SCROFA PITUITARY GLAND · 200 [hp_X]/30mL
INTERLEUKIN-10 · 4 [hp_C]/30mL
MELATONIN · 4 [hp_C]/30mL
SODIUM PYRUVATE · 3 [hp_X]/30mL
PHYTOLACCA AMERICANA ROOT · 6 [hp_X]/30mL
SUS SCROFA PINEAL GLAND · 6 [hp_X]/30mL
RANCID BEEF · 30 [hp_X]/30mL
TRANSFORMING GROWTH FACTOR BETA-1 · 4 [hp_C]/30mL

Registration

Registration number: 17089-417
Registration status: Active
Dispensing: Over the counter
Route: ORAL

Sources

product · openFDA NDC · 17089-417 · Verified 2026-10-09 · open in source
registration_status · openFDA NDC · 17089-417 · Verified 2026-10-09 · open in source
ingredients.0 · openFDA NDC · 17089-417 · Verified 2026-10-09 · open in source
ingredients.1 · openFDA NDC · 17089-417 · Verified 2026-10-09 · open in source
ingredients.2 · openFDA NDC · 17089-417 · Verified 2026-10-09 · open in source
ingredients.3 · openFDA NDC · 17089-417 · Verified 2026-10-09 · open in source
ingredients.4 · openFDA NDC · 17089-417 · Verified 2026-10-09 · open in source
ingredients.5 · openFDA NDC · 17089-417 · Verified 2026-10-09 · open in source
ingredients.6 · openFDA NDC · 17089-417 · Verified 2026-10-09 · open in source
ingredients.7 · openFDA NDC · 17089-417 · Verified 2026-10-09 · open in source
ingredients.8 · openFDA NDC · 17089-417 · Verified 2026-10-09 · open in source
ingredients.9 · openFDA NDC · 17089-417 · Verified 2026-10-09 · open in source
ingredients.10 · openFDA NDC · 17089-417 · Verified 2026-10-09 · open in source
ingredients.11 · openFDA NDC · 17089-417 · Verified 2026-10-09 · open in source
ingredients.12 · openFDA NDC · 17089-417 · Verified 2026-10-09 · open in source
ingredients.13 · openFDA NDC · 17089-417 · Verified 2026-10-09 · open in source
ingredients.14 · openFDA NDC · 17089-417 · Verified 2026-10-09 · open in source
ingredients.15 · openFDA NDC · 17089-417 · Verified 2026-10-09 · open in source
ingredients.16 · openFDA NDC · 17089-417 · Verified 2026-10-09 · open in source
ingredients.17 · openFDA NDC · 17089-417 · Verified 2026-10-09 · open in source
ingredients.18 · openFDA NDC · 17089-417 · Verified 2026-10-09 · open in source